HomeBUSINESS
BUSINESS

Astellas Inks Collaboration with Universal Cells to Develop Novel Cell Therapy
(Oct.23.2017)

Astellas Pharma and Seattle-based Universal Cells said on October 19 that they have concluded an exclusive worldwide license pact for the R&D and commercialization of a novel cell therapy that surmounts the challenge of immune rejection ...
(LOG IN FOR FULL STORY)

News Calendar